NCT05034289 Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy Status COMPLETED Phase NA
NCT05032950 Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants Status COMPLETED Phase PHASE1
NCT05032690 Evaluation of the Relative Bioavailability of Bosutinib Capsules Under Fed Condition and Estimation of Food Effect on Orally Administered Bosutinib Capsule Status COMPLETED Phase PHASE1
NCT05022563 Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea Status COMPLETED Phase N/A
NCT05020236 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments Status RECRUITING Phase PHASE3
NCT05020145 COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States Status COMPLETED Phase N/A
NCT05018728 The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia Status TERMINATED Phase PHASE2
NCT05014412 A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment Status COMPLETED Phase PHASE2
NCT05012865 Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART) Status COMPLETED Phase N/A
NCT05012644 Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone Status COMPLETED Phase N/A
NCT05011513 Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). Status TERMINATED Phase PHASE2/PHASE3
NCT05005312 Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332 Status COMPLETED Phase PHASE1
NCT04998877 Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04996004 A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma Status TERMINATED Phase PHASE2
NCT04987944 Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma Status TERMINATED Phase PHASE1
NCT04987931 Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase N/A
NCT04985266 A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer Status RECRUITING Phase PHASE2